Acrylic bone cements have an elastic modulus several times higher than the surrounding trabecular bone. This has been hypothesized to contribute to certain clinical complications. There are indications that the addition of specific fatty acids and triglyceride oils may reduce the elastic modulus of these types of cements. Some of these additives also appear to have inherent antibiotic properties, although this has never been evaluated in bone cements. In this study, several types of fatty acids and triglyceride oils were evaluated for use in acrylic bone cements. Their mechanical properties were evaluated under uniaxial compression testing and selected cements were then further characterized in terms of microstructure, handling and antibacterial properties using scanning electron microscopy, polymerization temperature measurements, agar diffusion tests and bactericidal activity assays of cement extracts. It was found that any of the evaluated fatty acids or triglyceride oils could be used to tailor the stiffness of acrylic bone cements, although at varying concentrations, which also depended on the type of commercial base cement used. In particular, the addition of very small amounts of linoleic acid (<2.0 wt%) resulted in Young's moduli and compressive strengths in the range of human trabecular bone, while maintaining a similar setting time. Further, the addition of 12.6 wt% ricinoleic acid to Osteopal V cement was found to have a significant antibacterial effect, inhibiting growth of Staphylococcus aureus in an agar diffusion test as well as demonstrating 100% bactericidal activity against the same strain.
Introduction
Acrylic bone cements, mainly based on poly(methyl methacrylate) (PMMA), have been used in orthopedics since the 1960s for joint prosthesis fixation and since the 1980s for vertebroplasty, and are still extensively used. [1] [2] [3] These cements are readily available as a system consisting of a liquid and a powder to be mixed and applied in a liquid form as an injectable material or in a more viscous form as a paste. They can also be used in their set state as e.g. beads or spacers for local treatment of infection. 4 A basic formulation consists of (a) a powder, which is composed of prepolymerized polymer beads mixed with a radical initiator, typically benzoyl peroxide, and a radiopacifier, typically barium sulphate or zirconium dioxide; and (b) a liquid, which is composed of acrylic monomer, and a peroxide decomposer, typically N,N-dimethyl-p-toluidine. Some formulations contain other additives such as dyes, 5 used to differentiate the cement from the bone in the case of open surgery or explantation; bioactive fillers, 6 used with the aim of enhancing bone integration; additional radiopacifier, for enhanced visibility in minimally invasive applications 7, 8 and antibiotics, to prevent or treat infection. 4, 7 Although these additives are available in commercial formulations, cements are sometimes modified directly in the operating theater with some of these additives, e.g. through the addition of extra radiopacifier to cements intended for prosthesis fixation, 7, 8 or through the addition of antibiotics. 4, 7 Besides the above modifications, experimental formulations containing e.g. plasticizers have been investigated in order to reduce the stiffness of the cements. 9 This is because the excessive stiffness of acrylic bone cements in comparison to the surrounding trabecular bone may contribute to biomechanically related complications, mainly noted after vertebroplasty. [10] [11] [12] [13] In fact, most commercial acrylic bone cements have an elastic modulus in the range of 1700-3700 MPa, 14, 15 while the elastic modulus of vertebral trabecular bone is typically in the ranges of 10-750 MPa, [16] [17] [18] encompassing osteoporotic to healthy bone. New fractures occurring after vertebroplasty may partly be due to the underlying disease, but some studies have reported a larger amount of new fractures next to the vertebrae treated with PMMA. [19] [20] [21] The maximum filling approach, in which as much cement as possible is injected into the vertebra, has been suggested to have a particularly detrimental effect. 22, 23 However, the stiffness and strength of vertebrae have been found to be only weakly correlated with the volume fill, [24] [25] [26] suggesting that even relatively small amounts of high-stiffness PMMA cements may induce a large increase in stiffness. Several experimental studies have therefore focused on developing novel PMMAbased cements with a lower elastic modulus by using additives such as hydrogels 27, 28 or lactam plasticizers. 29 Even though these attempts have proved successful in terms of tailoring the mechanical properties of the cements, none of these cements are commercially available. One reason for this could be that an excessive particle release has been found when aqueous phases are used in PMMA to obtain a reduced modulus. 30 Unsaturated fatty acids, which esterified to glycerol form triglycerides, are natural compounds that have recently been given more attention in chemical processes because of their potential for chemical modifications due to unsaturations and carboxyl groups in their structure. 31 Different approaches to incorporate compounds from this family into bone cements have been attempted. For instance, Va´zquez et al. 32 used aromatic amines as well as acrylic monomers, both derived from oleic acid, as components to improve bone cements. The authors reported similar compressive strength and a reduction of 62% in the Young's modulus when a modified liquid phase containing 2.57 wt% 4-N,N-dimethylaminobenzyl oleate was used. 32 Lam et al. 33 modified bone cements with strontium-substituted hydroxyapatite nanoparticles and linoleic acid, and reported a reduction of 15% in compressive strength and 57% in the Young's modulus when 15 vol% linoleic acid was incorporated into the liquid phase. In previous work, we added castor oil to commercially available PMMA and found that 12 wt% castor oil decreased the strength and the Young's modulus by 83% and 70%, 34 respectively. However, the castor oil appeared to interfere with the setting reaction, reducing the cell viability in a worst-case scenario. 34 Although further, preliminary testing has suggested that a modification of the monomerto-additive ratio could improve biocompatibility, the possibility of using another type of fatty acid or derivative thereof, which requires lower concentrations, remains an interesting opportunity. However, there is no systematic study available comparing different types of modifiers in PMMA bone cement. One aim of this study was therefore to screen different compounds in the fatty acid/triglyceride oil family to select the most suitable additive to control the mechanical properties of commercial bone cements for vertebroplasty. Furthermore, since these compounds could remain unreacted and provide an increase in intermolecular free volume, there may be an additional positive effect in terms of the drug release of the cement. PMMA cements alone have a limited drug delivery capacity, with the main delivery stemming from the surface of the cement, which means an excessive amount of drug has to be incorporated into the cement. A large quantity of the drug remains inside the cement and slowly leaks out, possibly causing increased bacterial resistance in the case of antibiotics. 35 Unreacted additive molecules may provide additional paths for drug release and hence an enhanced drug delivery from the PMMA cement, requiring less antibiotic addition. Furthermore, some of the compounds of interest have demonstrated inherent antibiotic properties and could therefore enhance the effect of an incorporated antibiotic. 36, 37 However, to the authors' knowledge, no report is available on the antibacterial effect of combining a fatty acid with an antibiotic. A second aim of this study was hence to evaluate the antibacterial properties of modified cements, with and without antibiotics. To meet the aims of the study, various commonly found fatty acids and triglyceride oils, namely ricinoleic acid, methyl linoleate, linoleic acid, tung oil, linseed oil and castor oil, were incorporated into two types of commercial bone cements for screening. The mechanical properties were evaluated under uniaxial compression and selected cements were then further characterized in terms of microstructure, handling, antibacterial properties and monomer release using scanning electron microscopy (SEM), polymerization temperature measurements, agar diffusion tests and bactericidal activity assays as well as monomer content of cement extracts.
Materials and methods

Material preparation
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise specified. A cement intended for vertebroplasty, Osteopal V (OP; Heraeus Medical GmbH, Hanau, Germany) was used as one base cement. Osteopal V has a liquid-to-powder ratio of 0.385 ml/g and the powder phase contains 54.6 wt% poly(methyl acrylate-co-methyl methacrylate), 45.0 wt% zirconium dioxide, 0.4 wt% benzoyl peroxide and chlorophyll VIII. The monomer phase contains 92 wt% methyl methacrylate, 2 wt% N,N-dimethyl-ptoluidine and 6 wt% other additives including chlorophyll VIII and hydroquinone. A cement for prosthesis fixation, Simplex P (SP; Stryker Corporation, Kalamazoo, MI, USA) was also used as base cement, however for mechanical testing only, to confirm the concept for these types of cements. Simplex P has a liquid-to-powder ratio of 0.5 ml/g and the powder phase contains 73.7 wt% poly(methyl methacrylateco-styrene), 15 wt% poly(methyl methacrylate), 10 wt% barium sulphate, 1.7 wt% benzoyl peroxide. The monomer phase contains 97.5 wt% methyl methacrylate and 2.5 wt% N,N-dimethyl-p-toluidine. The following compounds in the fatty acid/triglyceride oil family were tested as additives: linoleic acid (LA; !99%), ricinoleic acid (RA; $80%), methyl linoleate (ML; !99%), tung oil (TO), linseed oil (LO) and castor oil (CO). Modified cements were prepared by first removing 54% of the additive volume from the monomer phase. The additive was then added to the monomer and the modified monomer phase was homogenized using a Vortex-Genie 2 mixer (Scientific Industries, Bohemia, NY, USA) prior to cement preparation. The bone cements were prepared by adding the monomer phase to the powder phase inside 50 mL Falcon tubes, and then mixed for 30 s using a capvibrator (Ivoclar Vivadent AB, Solna, Sweden).
Mechanical testing
Specimens of ø ¼ 6 mm and h ¼ 12 mm were tested after 24 h setting in air at room temperature. 38 Uniaxial compression tests were performed under displacement control at 6 mm/min using an AGS-X materials testing machine (Shimadzu, Kyoto, Japan). The Young's modulus (E) and compressive strength (s c ) (yield stress at 2% offset or upper yield point, whichever occurred first 38 ) were determined from the stress-strain data. Since different additives affected the properties to different extent, various concentrations were tested until cements with a combination of a Young's modulus below 750 MPa and a strength above 10 MPa were obtained, since such Young's modulus is in the upper range of elastic moduli of vertebral trabecular bone, 16, 18 and the strength corresponds to the highest values reported for vertebral trabecular bone 17 (although mixed with femoral specimens -other highest values reported for vertebral trabecular bone lie at approx. 5 MPa 18 ). Based on the results, a few compositions were selected for further characterization, as further detailed in the section on Mechanical properties.
Microstructure
The microstructure of the cements was examined by SEM. The images were acquired on a LEO 1550 SEM (Carl Zeiss AG, Oberkochen, Germany) operated at an acceleration voltage of 2.00 kV, with a secondary electron detector for topographic contrast, and at a working distance of 10 mm. Prior to SEM imaging, the samples were polished down to 1200 grit and sputter-coated with palladium. The samples were prepared 24 h prior to polishing and then stored under vacuum overnight prior to coating.
Handling properties
The maximum polymerization temperature (T max ) and the setting time (t setting ), defined as the time taken to reach a temperature midway between ambient and maximum temperature, were determined according to the standard procedure described in ISO 5833, with four replicates per group. 38 The glass transition temperature of the cements was assessed through differential scanning calorimetry using a DSC Q1000 (TA Instruments, United States). A heat/cool/heat ramp experiment was performed using a heating rate of 10 C/min up to 200 C and a cooling rate of 20 C/ min, down to -80 C. The glass transition temperature was determined from the second heat ramp.
Antimicrobial properties
Vancomycin was added to selected cements in order to evaluate the antibacterial properties of the modified cements as well as the effect of combining a fatty acid or its derivative with an antibiotic. Vancomycin was chosen as it is commonly used in PMMA bone cement for revision arthroplasty. 39, 40 The antibacterial activity of the samples was tested using the gram-positive bacterium Staphylococcus aureus (Culture Collection, University of Go¨terborg, Sweden). S. aureus was grown and maintained in Brain Heart Infusion (BHI) broth (Scharlau, Spain). The culture was incubated overnight at 37 C before each assay and the assays were performed in static conditions due to the short testing time.
Agar diffusion test. The relative antibacterial activity of selected formulations with and without antibiotic (2.4 wt% of powder 39 ) was determined through an agar diffusion test. The test was performed by spreading 200 ml of bacterial suspension (1Á10 8 colony forming units (CFU)/ml, O.D. of 0.2 AE 0.01 at 600 nm) homogenously on every BHI agar plate, previously prepared with the appropriate culture media containing 1.5% bacteriological agar (Scharlau, Spain). Disc-shaped specimens (ø ¼ 7 mm; h ¼ 3.5 mm) of cements were prepared and four equidistant cavities of the same size were punched in the agar and the specimens placed inside, after 1 h of setting in air at room temperature. Images of the specimens were taken with a digital camera after incubation for 24 h at 37 C. The inhibition zone size was calculated as the mean difference between the inhibition zone diameter and the cement-filled cavity diameter. Six replicates were performed per formulation.
Bactericidal assay. The antimicrobial activity of cement extracts was assessed using disc-shaped specimens (ø ¼ 7.5 mm; h ¼ 2 mm) of cements. Extracts were prepared by soaking the cements, after 1 h of setting in air at room temperature, in phosphate buffered saline (PBS) solution according to the ISO 10993 standard at a surface-to-PBS medium of 3 cm 2 /ml for 24 h at 37 C. 41 S. aureus (2 Â 10 5 CFU/ml) was incubated in the cement extracts for 2 h at 37 C; 100 ml aliquots from these extracts were subsequently spread on agar plates, and the number of surviving colonies counted after incubation for 24 h at 37 C. The percentage of surviving colonies was calculated with respect to the surviving colonies in the positive control (PBS only). Four replicates per formulation were performed.
Monomer release
Extracts were prepared after 1 h of setting in air at room temperature, using six specimens (ø ¼ 7.7 mm, h ¼ 3.5 mm) per group. Extractions were done for each group by submerging all six specimens in 3.55 ml PBS for 24 h at 37 C, similarly to the antibacterial tests. Afterwards, 2 ml aliquots from each solution were introduced in a head space vial and closed hermetically. The vials were incubated at 80 C during 30 min. The analysis was performed by gas chromatography-mass spectrometry (HS-GC/MS), by injecting 1 ml of the vapor phase through a special syringe kept at 85 C. A Trace GC Gas Chromatograph with Triplus head space injector coupled to a DSQII mass spectrometer (ThermoFisher Scientific, Waltham, MA) was used. A ZB-624 column (60 m Â 0.32 mm Â 1.8 m) with a helium flow of 1.8 ml/min was used for separation. The oven temperature programme consisted of 2-min hold at 60 C, followed by 8 C/min ramp to 220 C and a 5min hold at 220 C. The temperature of the injector, interface and ionization source was set at 220, 260 and 200 C, respectively.
Statistical analysis
IBM SPSS Statistics v. 21 (IBM, Chicago, IL, USA) was used to perform analyses of variance (ANOVA) followed by Scheffe's post-hoc test in order to evaluate statistical differences between groups. When homogeneity of variance could not be confirmed (using Levene's test), Welch's robust test of equality of means was used together with Tamhane's post-hoc test. A significance level of a ¼ 0.05 was used.
Results
Mechanical properties
The properties of the base (control) cements in which the additives were evaluated are summarized in Table 1 . Table 2 shows the mechanical properties of Simplex P and Osteopal V modified with fatty acids: ricinoleic acid, linoleic acid methyl ester (methyl linoleate) and linoleic acid. Linoleic acid as well as its methyl ester had a more pronounced effect on the Young's modulus of both Simplex P and Osteopal V compared to ricinoleic acid. Table 3 shows the mechanical properties of Simplex P and Osteopal V modified with triglyceride oils: linseed oil, tung oil and castor oil. Linseed oil and tung oil had a more pronounced effect on the Young's modulus than castor oil. In general, lower amounts of additive were required to reach similar mechanical properties for Osteopal V than for Simplex P.
Two fatty acids (linoleic acid and ricinoleic acid) and one triglyceride oil (castor oil) were selected for further testing with Osteopal V: more ricinoleic acid than linoleic acid or methyl linoleate was needed for the same 
Microstructure
The surface microstructure of Osteopal V and its modified low-modulus formulations was assessed through SEM ( Figure 1 ). Osteopal V modified with linoleic acid (Figure 1b ) exhibited a similar microstructure to that of unmodified Osteopal V (Figure 1a ), displaying a dense, highly polymerized material, with no major features. On the other hand, low-modulus Osteopal V modified with ricinoleic acid and castor oil (Figure 1c and d, respectively) exhibited a more irregular porous surface where the spherical polymer beads (20-90 mm) as well as the irregular zirconia particles (used as radiopacifier) were distinguishable.
Handling properties
The handling properties of the selected cements are shown in Table 5 . The setting times of cements containing ricinoleic acid and castor oil were significantly lower than that of the control (p 0.001), but there was no significant difference between the two (p > 0.05). All low-modulus formulations gave significantly lower polymerization temperatures than the unmodified cement (p < 0.001), but no difference was found between the modified cements (p > 0.05).
Antimicrobial properties
The inhibitory zones resulting from the agar diffusion test are shown in Figure 2 (a). Unmodified Osteopal V showed virtually no inhibitory zone. A clear inhibitory effect was however observed for all the formulations when Vancomycin was added (p 0.01). An inhibitory effect could also be seen for the formulations without antibiotic but containing other additives, although this effect was statistically significant for ricinoleic acid only (p < 0.001, in comparison to unmodified Osteopal V).
The results for the bactericidal activity of the extracts are shown in Figure 2 (b) as percentage of viable bacteria in comparison to PBS only. Unmodified Osteopal V was significantly different only to cements containing ricinoleic acid, with or without antibiotic (p ¼ 0.02), which both showed the highest bactericidal activity (no viable bacteria). No difference was found between groups with and without antibiotic, except for cements containing linoleic acid (p ¼ 0.01).
Monomer release
HS-GC/MS gave a concentration of MMA in the extracts of 1.40, 2.13, 0.75 and 0.96 g/l for OP, 
Discussion
In this study different fatty acids and triglyceride oils were tested as potential additives to acrylic bone cements with two purposes: (A) to tailor the Young's modulus towards values closer to those of human trabecular bone; (B) to achieve enhanced antibacterial properties of the cements. To screen the applicability of these compounds in the clinical setting we chose two base cements, Osteopal V, intended for vertebroplasty, and Simplex P, intended for prosthesis fixation. The results for the mechanical properties clearly indicated that among the tested fatty acids, linoleic acid and its methyl ester had the largest effect on the final values since lower additive concentrations were required to achieve properties similar to human trabecular bone ( Table 2 ). The reason for this could be the increased availability of the end hydrogen atom for abstraction in combination with the polyunsaturation of linoleic acid and its methyl ester in comparison to ricinoleic acid. The level of unsaturation of a fatty acid or a triglyceride is commonly measured in terms of the iodine value (the mass of iodine in grams that is consumed by 100 g of a substance), which is 181.0 and 85.1 mg for linoleic and ricinoleic acid, respectively, 31 indicating that a higher iodine value increases the reactivity of the fatty acid within the bone cement. Methacrylation of the polyunsaturated fatty acids can occur via chain transfer. 42 Previous studies on a similar type of reaction have suggested that the methyl methacrylate (MMA) radicals may graft by abstraction of the alpha-hydrogen in the fatty acid. 42 Thereby, fatty acids reduce the modulus of the cement through grafting and formation of stable radicals that slow down the polymerization and shorten the chains. 42 Also, the presence of these large molecules increases the free volume and facilitates the relative movement of the polymer chains, thereby decreasing the glass transition temperature and lowering the elastic modulus of the material, as seen in Table  5 . The results also indicated that among the tested triglyceride oils, linseed and tung oil had the largest effect on the final mechanical properties ( Table 3 ). The major components of linseed, tung and castor oil are linolenic acid (55%), a-Eleostearic acid (82.0%) and ricinoleic acid (87.5%), respectively. 31 The iodine values for triglycerides from these fatty acids are 261.6 mg for linolenic and a-Eleostearic acid and 81.6 mg for ricinoleic acid. This indicates that, also for the triglyceride oils, the higher efficacy in decreasing the mechanical properties stems from the reactivity of the additive. Larger amounts of additives were generally required in Simplex P compared to Osteopal V to reach similar moduli. This followed from the relative amounts of cement components (see section on Material preparation): in order to reach a similar additive to monomer ratio, a larger weight percentage of the total cement was needed in Simplex P. Interestingly, a much lower vol% (approximately 3 vol% compared to 15 vol%) of linoleic acid was needed to achieve a similar reduction in modulus in the current study compared to the study by Lam et al. 33 However, in the study by Lam et al., the cements also contained 20 wt% (of powder) linoleicacid functionalized strontium substituted hydroxyapatite particles, which hence appeared to limit the effect of the added linoleic acid, possibly due to the hypothesized formation of a copolymer on the particle-cement interface. 33 The setting time decreased for the cements containing ricinoleic acid and castor oil compared to the control, while the cement containing linoleic acid gave no significant difference. The use of fatty acids or triglyceride oils also had a positive effect on the peak polymerization temperature, which was reduced by almost 30 C. A reduction in peak polymerization temperature could be beneficial from a clinical perspective, as high polymerization temperatures may have negative effects on surrounding tissues. 43, 44 It can be noted, however, that the amounts used to measure the setting time and maximum temperature according to the standard 38 are much larger than those used in e.g. vertebroplasty. The additives reduced the glass transition temperature of the modified cements, which could be due to shorter polymer chains besides increased interchain spacing as explained above. The decrease in setting time, polymerization temperature and glass transition temperature of cements containing ricinoleic acid and castor oil could also be related to the smaller amount of monomer that was available to react in these formulations (see section on Material preparation). Since the activator was present in excess in the liquid phase, approximately the same number of reactions could be started by the initiator from the powder phase, giving a shorter setting time and shorter chains. In fact, the SEM images ( Figure 1 ) indicated that the morphology of these cements was not homogeneous, being affected by the presence of a non-polymerizing phase. Conversely, the cement containing linoleic acid appeared homogeneous and its setting time was not significantly affected.
The agar diffusion test showed that the antibiotic Vancomycin was released from all the materials creating an inhibitory zone that prevented the growth of S. aureus (Figure 2a ). No significant improvement in inhibitory effect was detected as a result of any of the additives, despite the apparently more open structure of the ricinoleic acid and castor oil-containing cements. However, the test confirmed that the materials containing fatty acids or a triglyceride oil had a certain inhibitory effect even without added antibiotic. 36, 37 Regarding the bactericidal activity of cement extracts (Figure 2b) , a difference due to the addition of antibiotic was found for cements containing linoleic acid only, likely due to relatively large variances in some cases together with the limited number of specimens (3-4 per group). In fact, in a previous study, where a similar amount of Vancomycin in another commercial formulation (Cemex XL, Tecres) was used, 39 a bactericidal activity was found without other additives than the antibiotic. However, much larger cement disks were used (ø ¼ 15 mm; h ¼ 10 mm compared to our ø ¼ 7.5 mm; h ¼ 2 mm), together with a lower seeding density (1Á10 5 CFU/ml in comparison to our 2Á10 5 CFU/ml). Similarly to the agar test, the additives used in the present study appeared to give a bactericidal effect of their own, but a significant difference to the control was detected only for cements containing ricinoleic acid, which showed 100% bactericidal activity, i.e. no viable bacteria was detected, regardless of the use of antibiotic. Although, to the best of the authors knowledge, there is no data available on the antibacterial effects of ricinoleic acid itself, some of its derivatives have been found to have antibacterial properties. 45 Residual monomer may have toxic effects; 46 however, the monomer release study confirmed that the bactericidal effect of ricinoleic acid-containing cements was not likely to be due to an increase in monomer release from these cements. In fact, the ricinoleic acid-as well as the castor oil-containing cements gave a lower monomer release than the control, possibly due to the removal of monomer from the original composition during preparation of these cements (see section on Material preparation) and the faster setting. Any possible negative biological effect of the ricinoleic acid-containing cements however needs to be evaluated in a future study. The addition of linoleic acid, which entailed removal of much less monomer than for the other modified cements, gave a higher monomer release than the control, possibly due to the reduced polymerization rate, as discussed above. However, preliminary data indicate that although linoleic acid-and castor oil-containing cements give a lower cell viability for osteoblast-like Saos-2 cells in contact with undiluted extracts, dilutions of as little as 4-10 times give viabilities not significantly different to the control (data not shown). Future work should include in vivo evaluation of the cements' biocompatibility as well as further studies elucidating the possible antibacterial effect of the ricinoleic acid. Further, it should be noted that, while in the current study a lower modulus was aimed for, the modifications also entailed a lower strength. A strength of above 10 MPa was set as the limit, in line with literature values for vertebral trabecular bone. 17, 18 However, while this may be adequate for the vertebroplasty application, the ISO standard for acrylic cements for prosthesis fixation cites a minimum strength of 70 MPa. 38 Hence, while the use of the additives could be useful for lowering the modulus of vertebroplastic cements, and/ or achieving antibacterial properties without the need for an additional antibiotic, the use of these cements in other applications may be restricted to limited or nonload-bearing situations, such as beads for the local treatment of infection. 47 In summary, PMMA-based cements with a lower elastic modulus as well as improved antibacterial properties were produced using fatty acids and triglyceride oils. Whereas low-modulus cements modified with small amounts of linoleic acid gave a similar morphology to unmodified cements, low-modulus cements containing much higher amounts of ricinoleic acid and castor oil gave a more porous structure. Ricinoleic acid appeared to have inherent antibacterial properties.
Conclusion
The addition of fatty acids or triglyceride oils is a simple and effective method to modify the properties of existing commercial bone cements or to design new bone cements with bone-compliant mechanical properties and antibacterial properties. Specifically, very small amounts of linoleic acid (<2.0 wt%) can be used to obtain Young's moduli and compressive strengths in the range of human trabecular bone. Further, the addition of 12.6 wt% ricinoleic acid to Osteopal V cement was found to have a significant antibacterial effect, inhibiting growth of S. aureus in an agar diffusion test as well as demonstrating 100% bactericidal activity against the same strain. This suggests that ricinoleic acid could replace commonly used antibiotics in some instances, e.g. in pre-polymerized beads; whereas if only a reduction in modulus is desired, linoleic acid could be used, e.g. in vertebroplasty.
